6 Conclusions

6 Conclusions

6.1 The Committee recognised that there are uncertainties in the clinical evidence and cost model, but the available data support a cost saving associated with use of SeQuent Please balloon catheter under the conditions set out in sections 1.2 and 1.3.

6.2 There may be additional advantages related to reduced duration of clopidogrel therapy and increased treatment options if further restenosis occurs, compared with the use of stenting for in-stent restenosis.

  • National Institute for Health and Care Excellence (NICE)